The carboxyl terminus of V-Abl protein can augment SH2 domain function

Journal of Virology

Volumn 74, Issue 10, 2000, Pages 4495-4504

  Warren, David ^a   Heilpern, Andrew J ^a   Berg, Kent ^a   Rosenberg, Naomi ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN TYROSINE KINASE; VIRUS PROTEIN;

ABELSON MURINE LEUKEMIA ONCOVIRUS; ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; EMBRYO; ENZYME SPECIFICITY; GENE EXPRESSION; GENE FUNCTION; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; ONCOGENE RAS; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

3T3 CELLS; ABELSON MURINE LEUKEMIA VIRUS; ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADAPTOR PROTEINS, VESICULAR TRANSPORT; ANIMALS; CELL LINE; CELL TRANSFORMATION, VIRAL; DNA-BINDING PROTEINS; ENZYME ACTIVATION; FUNGAL PROTEINS; GATA TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION, VIRAL; GENES, FOS; GENETIC COMPLEMENTATION TEST; GRB2 ADAPTOR PROTEIN; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; ONCOGENE PROTEINS V-ABL; PHOSPHORYLATION; PROTEINS; RAS PROTEINS; RECOMBINANT FUSION PROTEINS; SRC HOMOLOGY DOMAINS;

EID: 0033997589     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.74.10.4495-4504.2000     Document Type: Article

References (70)

1. Afar, D. E. H., A. Goga, J. McLaughlin, O. N. Witte, and C. L. Sawyers. 1994. Differential complementation of Bcr-Abl point mutants with c-Myc. Science 264:424-426.
2. Baskaran, R., M. E. Dahmus, and J. Y. Wang. 1993. Tyrosine phosphorylation of mammalian RNA polymerase II carboxyl-terminal domain. Proc. Natl. Acad. Sci. USA 90:11167-11171.
3. Berkowitz, L. A., K. T. Riabowol, and M. Z. Gilman. 1989. Multiple sequence elements of a single functional class are required for cyclic AMP responsiveness of the mouse c-fos promoter. Mol. Cell. Biol. 9:4272-4281.
4. Cahil, M. A., R Janknecht, and A. Nordheim. 1996. Signalling pathways: Jack of all cascades. Curr. Biol. 6:16-19.
5. Chesebro, B., K. Wehrly, M. Cloyd, W. Britt, J. Portis, J. Collins, and J. Nisho. 1981. Characterization of mouse monoclonal antibodies specific for Friend murine leukemia virus-induced erythroleukemia cells: Friend-specific and FMR-specific antigens. Virology 112:131-144.
6. Dai, Z., and A. M. Pendergast. 1995. Abi-2, a novel SH3-containing protein interacts with the c-Abl tyrosine kinase and modulates c-Abl transforming activity. Genes Dev. 9:2569-2582.
7. Danial, N. N., J. A. Losman, T. Lu, N. Yip, K. Krishnan. J. Krolewski, S. P. Goff, J. Y. Wang, and P. B. Rothman. 1998. Direct interaction of Jak 1 and v-Abl is required for v-Abl-induced activation of STATs and proliferation. Mol. Cell. Biol. 18:6795-6804.
8. Danial, N. N., A. Pernis, and P. B. Rothman. 1995. Jak/STAT signaling induced by the v-Abl oncogene. Science 269:1875-1877.
9. Davis, R. J. 1999. Signal transduction by the c-Jun N-terminal kinase. Biochem. Soc. Symp. 64:1-12.
10. de Rooij. J., and J. L. Bos. 1997. Minimal Ras-binding domain of Raf 1 can be used as an activation-specific probe for Ras. Oncogene 14:623-625.
11. ras in activation of extracellular regulated kinase 2. Nature (London) 357:602-604.
12. Dubridge, R. B., P. Tang, C. Hsia, P. M. Leong, J. H. Miller, and M. P. Calos. 1987. Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system. Mol. Cell. Biol. 7:379-387.
13. Dudek, H., S. R. Datta, T. F. Franke, M. J. Birnbaum, R. Yao, G. M. Cooper, R. A. Segal, D. R. Kaplan, and M. E. Greenberg. 1997. Regulation of neuronal survival by the serine-threonine protein kinase Akt. Science 275: 661-664.
14. Engelman, A., and N. Rosenberg. 1987. Isolation of temperature-sensitive Abelson virus mutants by site-directed mutagenesis. Proc. Natl. Acad. Sci. USA 84:8021-8025.
15. Feller, S. M., B. Knudsen, and H. Hanafusa. 1994. c-Abl kinase regulates the protein binding activity of c-Crk. EMBO J. 13:2341-2351.
16. Goga, A., J. McLaughlin, D. E. H. Afar, D. C. Saffran, and O. N. Witte. 1995. Alternative signals to Ras for hematopoietic transformation by the Bcr-Abl oncogene. Cell 82:981-988.
17. Gupta, S., H. Yan, L. H. Wong, S. Ralph, J. Krolewski, and C. Schindler. 1996. The SH2 domains of Stat1 and Stat2 mediate multiple interactions in the signal transduction of IFN-α signals. EMBO J. 15:1075-1084.
18. Hanks, S. K., A. M. Quinn, and T. Hunter. 1988. The protein kinase family: conserved features and deduced phylogeny of the catalytic domains. Science 241:42-51.
19. Hann, R. S., M. W. King, D. L. Bentley, C. W. Anderson, and R. N. Eisenman. 1988. A non-AUG translational initiation in c-myc exon 1 generates an N-terminally distinct protein whose synthesis is disrupted in Burkitt's lymphomas. Cell 52:185-195.
20. Harvat, B. L., and W. Wharton. 1995. Serum response element and flanking sequences mediate the synergistic transcriptional activation of c-fos by 12-O-tetradecanoylphorbol-13-acetate and cholera toxin in AKR-2B cells. Cell Growth Differ. 6:955-954.
21. ras and the Ras-binding domain of the human Raf-1 protein kinase. J. Biol. Chem. 270:2901-2905.
22. Hevezi, P., K. Alin, and S. P. Goff. 1993. Transforming activity and tissue tropism of hybrid retroviral genomes containing portions of the v-abl and v-src oncogenes. Oncogene 8:2413-2423.
23. Hevezi, P., K. Alin, R. Rees-Jones, and S. P. Goff. 1992. Bone marrow-transforming activity of linker insertion mutants of Abelson murine leukemia virus. Oncogene 7:2323-2328.
24. Hill, C. S., J. Wynne, and R. Treisman. 1995. The Rho family GTPases RhoA, Rac 1, and CDC42Hs regulate transcriptional activation by SRF. Cell 81:1159-1170.
25. Hipskind, R. A., D. Buscher, A. Nordheim, and M. Baccarini. 1994. Ras/ MAP kinase-dependent and -independent signaling pathways target distinct ternary complex factors. Genes Dev. 8:1803-1816.
26. TCF. Nature (London) 354:531-534.
27. Karin, M. 1996. The regulation of AP-1 activity by mitogen-activated protein kinases. Philos. Trans. Roy. Soc. Lond. B 351:127-134.
28. Kim, D. W., V. Cheriyath, A. L. Roy, and B. H. Cochran. 1998 TFII-I enhances activation of the c-fos promoter through interactions with upstream elements. Mol. Cell. Biol. 18:3310-3320.
29. Kipreos, E. T., and J. Y. J. Wang. 1992. Cell cycle-regulated binding of c-Abl tyrosine kinase to DNA. Science 256:382-385.
30. Lai, K.-M. V., J. P. Olivier, G. D. Gish, M. Henkemeyer, J. McGlade, and T. Pawson. 1995. A Drosophila she gene product is implicated in signaling by the DER receptor tyrosine kinase. Mol. Cell. Biol. 15:4810-4818.
31. Marengere, L. E. M., Z. Songyang, G. D. Gish, M. D. Schaller, J. T. Parsons, M. J. Stearn, L. C. Cantley, and T. Pawson. 1994. SH2 domain specificity and activity modified by a single residue. Nature (London) 369:502-505.
32. Matuoka. K., F. Shibasaki, M. Shibata, and T. Takenawa. 1993. Ash/Grb-2, a SH2/SH3-containing protein, couples to signaling for mitogenesis and cytoskeletal reorganization by EGF and PDGF. EMBO J. 12:3467-3473.
33. Mayer, B. J., and D. Baltimore. 1994. Mutagenic analysis of the roles of SH2 and SH3 domains in regulation of the Abl tyrosine kinase. Mol. Cell. Biol. 14:2883-2894.
34. Mayer, B. J., and D. Baltimore. 1993. Signalling through SH2 and SH3 domains. Trends Cell Biol. 3:8-13.
35. Mayer, B. J., P. K. Jackson, R A. van Etten, and D. Baltimore. 1992. Point mutations in the Abl SH2 domain coordinately impair phosphotyrosine binding in vitro and transforming activity in vivo. Mol. Cell. Biol. 12:609-618.
36. McWhirter, J. R., and J. Y. J. Wang. 1991. Activation of tyrosine kinase and microfilament-binding functions of c-Abl by Bcr sequences in Bcr/Abl fusion proteins. Mol. Cell. Biol. 11:1553-1565.
37. Minden, A., A. Lin, M. McMahon, C. Lange-Carter, B. Derijard, R. J. Davies, G. L. Johnson, and M. Karin. 1994. Differential activation of ERK and JNK mitogen-activated protein kinases by Raf-1 and MEKK. Science 266:1719-1723.
38. Muller, A. J., A.-M. Pendergast, K. Parmar, M. H. Pavlik, N. Rosenberg, and O. N. Witte. 1993. En bloc substitution of the Src homology region 2 domain activates the transforming potential of the c-Abl protein tyrosine kinase. Proc. Natl. Acad. Sci. USA 90:3457-3461.
39. Muller, A. J., J. C. Young, A.-M. Pendergast, M. Pondel, N. R. Landau, D. R. Littman, and O. N. Witte. 1991. BCR first exon sequences specifically activate the BCR/ABL tyrosine kinase oncogene of Philadelphia chromosome-positive human leukemias. Mol. Cell. Biol. 11:1785-1792.
40. Murtagh, K., G. Skladany, J. Hoag, and N. Rosenberg. 1986. Abelson murine leukemia virus variants with increased oncogenic potential. J. Virol. 60: 599-606
41. Musacchio, A., T. Gibson, V. P. Lehto, and M. Saraste. 1992. SH3-an abundant protein domain in search of a function. FEBS Lett. 307:55-61.
42. Mysliwiec, T., R. Perego, and G. D. Kruh. 1996. Analysis of chimeric Gag-Arg/Abl molecules indicates a distinct negative regulatory role for the Arg C-terminal domain. Oncogene 12:631-640.
43. Norman, C., M. Runswick, R. Pollock, and R. Treisman. 1988. Isolation and properties of cDNA clones encoding SRF, a transcription factor that binds to the C-fos serum response element. Cell 55:989-1003.
44. Owen-Lynch, P. J., A. K. Y. Wong, and A. D. Whetton. 1995. v-abl-mediated apoptotic suppression is associated with she phosphorylation without concommitant mitogen-activated protein kinase activation. J. Biol. Chem. 270: 5956-5962.
45. Parmar, K., and N. Rosenberg. 1996. Ras complements the carboxyl terminus of v-Abl protein in lymphoid transformation. J. Virol. 70:1009-1015.
46. Pendergast, A. M., M. L. Gishizky, M. H. Havlik, and O. N. Witte. 1993. SH 1 domain autophosphorylation of p210 BCR/ABL is required for transformation but not growth factor independence. Mol. Cell. Biol. 13:1728-1736.
47. Pendergast, A. M., L. A. Quilliam, L. D. Cripe, C. H. Bassing, Z. Dai, N. Li, A. Batzer, K. M. Rabun, C. J. Der, J. Schlessinger, M. L. Gishizky. 1993. BCR-ABL-induced oncogenesis is mediated by direct interaction with the SH2 domain of the GRB-2 adaptor protein. Cell 75:175-185.
48. Pendergast, A. M., J. A. Traugh, and O. N. Witte. 1987. Normal cellular and transformation-associated Abl proteins share common sites for protein kinase C phosphorylation. Mol. Cell. Biol. 7:4280-4289.
49. Pruett, W., Y. Yuan, E. Rose, A. G. Batzer, N. Harada, and E. Y. Skolnik. 1995. Association between Grb2/Sos and insulin receptor substrate 1 is not sufficient for activation of extracellular signal-regulated kinases by interleukin-4: implications for ras activation by insulin. Mol. Cell. Biol. 15:1778-1785.
50. Prywes, R., J. G. Foulkes, N. Rosenberg, and D. Baltimore. 1983. Sequences of the A-MuLV protein needed for fibroblast and lymphoid cell transformation. Cell 34:569-579.
51. Puil, L., J. Liu, G. Gish, G. Mbamalu, D. Bowtell, P. G. Pelicci, R. Arlinghaus, and T. Pawson. 1994. Bcr-Abl oncoproteins bind directly to activators of the Ras signalling pathway. EMBO J. 13:764-773.
52. Raffel, G., K. Parmar, and N. Rosenberg. 1996. In vivo association of v-Abl with She mediated by a non-phosphotyrosine-dependent SH2 interaction. J. Biol. Chem. 271:4640-4645.
53. Raitano, A. B., J. R. Halpern, T. M. Hambuch, and C. L. Sawyers. 1995. The bcr-abl leukemia oncogene activates Jun kinase and requires Jun for transformation. Proc. Natl. Acad. Sci. USA 92:11746-11750.
54. Ren, R., Z.-S. Ye, and D. Baltimore. 1994. Abl protein-tyrosine kinase selects the crk adapter as a substrate using SH3-binding sites. Genes Dev. 8:783-795.
55. Renshaw, M. W., E. Lea-Chou, and Y. J. Wang. 1996. Rac is required for v-Abl tyrosine kinase to activate mitogenesis. Curr. Biol. 6:76-83.
56. Renshaw, M. W., J. R. McWhirter, and J. Y. J. Wang. 1995. The human leukemia oncogene bcr-abl abrogates the anchorage requirement but not the growth factor requirement for proliferation. Mol. Cell. Biol. 15:1286-1293.
57. Ridley, A. J., H. F. Paterson, C. L. Johnston, D. Diekmann, and A. Hall. 1992. The small GTP-binding protein rac regulates growth factor-induced membrane ruffling. Cell 70:401-410.
58. Rosenberg, N., D. R. Clark, and O. N. Witte. 1980. Abelson murine leukemia virus mutants deficient in kinase activity and lymphoid transformation. J. Virol. 36:766-774.
59. Rosenberg, N., and O. N. Witte. 1980. Abelson murine leukemia virus (A-MuLV) mutants with alterations in the A-MuLV-specific P120 molecule. J. Virol. 33:340-348.
60. Rosenberg, N., and O. N. Witte. 1988. The viral and cellular forms of the Abelson (abl) oncogene. Adv. Virus Res. 35:39-81.
61. Sadowski, H. B., K. Shuai, J. E. Darnell, Jr., and M. Z. Gilman. 1993. A common nuclear signal transduction pathway activated by growth factor and cytokine receptors. Science 263:1739-1744.
62. Sawyers, C. L., J. McLaughlin, and O. N. Witte. 1995. Genetic requirement for ras in the transformation of fibroblasts and hematopoietic cells by the bcr-abl oncogene. J. Exp. Med. 181:307-313.
63. Shaw, P. E., H. Schroter, and A. Nordheim. 1989. The ability of a ternary complex to form over the serum response element correlates with serum inducibility of the human c-fos promoter. Cell. 56:563-572.
64. Shi, Y., K. Alin, and S. P. Goff. 1995. Abl-interactor-1, a novel SH3 protein binding to the carboxy-terminal portion of the Abl protein, suppresses v-Abl transforming activity. Genes Dev. 9:2583-2597.
65. Smith, J. M., S. Katz, and B. J. Mayer. 1999. Activation of the Abl tyrosine kinase in vivo by Src homology 3 domains from the Src homology 2/Src homology 3 adaptor Nck. J. Biol. Chem. 274:27956-27962.
66. Songyang, Z., S. E. Shoelson, M. Chadhuri, G. Gish, T. Pawson, W. G. Haser, F. King, T. Roberts, S. Ratnofsky, R. J. Lechleider, B. G. Neel, R. B. Birge, J. E. Fajardo, M. M. Chou, H. Hanafusa, B. Schaffhausen, and L. C. Cantley. 1993. SH2 domains recognize specific phosphopeptide sequences. Cell 72:767-778.
67. Treisman, T. 1990. The SRE: a growth factor responsive transcriptional regulator. Semin. Cancer Biol. 1:47-58.
68. Van Etten, R. A., P. K. Jackson, D. Baltimore, M. C. Sanders, P. T. Matsudaira, and P. A. Janmey. 1994. The COOH terminus of the c-abl tyrosine kinase contains distinct F- and G-actin binding domains with bundling activity. J. Cell Biol. 124:325-340.
69. Wagner, B. J., T. H. Hayes, C. J. Hoban, and B. H. Cochran. 1990. The SIF binding element confers sis/PDGF inducibility onto the c-fos promoter. EMBO J. 9:4477-4484.
70. Zhigang, W., S. M. Thomas, R. J. Rickles, J. A. Taylor, A. W. Brauer, C. Seidel-Dugan, W. M. Michael, G. Dreyfuss, and J. S. Brugge. 1994. Identification of Src. Fyn, and Lyn SH3-binding proteins: implications for a function of SH3 domains. Mol. Cell. Biol. 14:4509-4521.